|
|
|
By Christopher Ohms, Ohms Consulting | These key technological advancements will significantly impact the pharma/biotech supply chain in 2025 and beyond. If you aren't implementing any of them yet, you may want to rethink your plans. |
|
|
|
By Paul J. Cummings, PJC Pharma Consulting Ltd. | Over the past few years, the pharma/biotech industry has seen a significant shift from internal to external manufacturing. This article examines the driving factors for what to expect in 2025. |
|
|
|
By Becky Upton, Ph.D., president, The Pistoia Alliance | The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab. |
|
|
|
|
|
|
|
|
|
|
|
